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ABSTRACT 
Proteins mediate the bulk of biological activity and are powerfully assayed in the diagnosis of diseases. Protein 
detection relies largely on antibodies, which have significant technical limitations especially when immobilised 
on two-dimensional surfaces. Here, we report the integration of peptide aptamers with extended gate metal-
oxide-semiconductor field-effect transistors (MOSFETs) to achieve label free sub-picomolar target protein 
detection. Specifically, peptide aptamers that recognise highly related protein partners of the cyclin-dependent 
kinase (CDK) family are immobilized on the transistor gate to enable human CDK2 to be detected at 100 fM or 
5 pg/ml, well within the clinically relevant range. The target specificity, ease of fabrication and scalability of 
these FET arrays, further demonstrates the potential application of the multiplexable field effect format to 
protein sensing. 
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1 
A detailed understanding of complex biological 
systems requires information about the functional 
state of proteins, which perform the bulk of the work 
on the cell. The introduction of monoclonal 
1
antibodies allowed the development of a number of 
robust detection techniques that are largely suitable 
for the detection of protein expression, one protein 
2
species at a time. The sequencing of the human 
genome has revealed that protein complexity is 
much more subtle than previously suspected, with 
multiple protein isoforms being encoded by 
relatively few genes: the genome of Homo sapiens 
comprises just 6,000 more genes than, for 
example, that of the nematode worm 
Caenorhabditis elegans (25,000 compared to 
19,000). Thus, genome sequencing and DNA 
microarrays have revealed that several variant 
messenger RNAs are made from each gene. 
Moreover, multiple protein isoforms carrying 
differential chemical modifications are made from 
each mRNA variant. New technologies that will 
allow the highly multiplexed detection of many 
highly related protein isoforms simultaneously are 
3
therefore now urgently sought. Our inability to 
detect, measure and monitor this complexity leads 
to a large gap in our ability to understand biology 
and devise new treatments for disease. Proteomics 
is currently playing a major role in cataloguing 
proteins, to great effect in many areas such as the 
4
identification of cancer biomarkers. However, the 
state-of-the-art technologies suffer from many 
limitations. For example, mass spectrometry is able 
to produce signatures indicating a pattern of protein 
expression, but cannot routinely simultaneously 
identify the proteins that constitute that pattern. In 
addition, whilst a catalogue of proteins expressed in 
a given situation is the first step to understanding 
the underlying biology, it is also necessary to be 
able to determine the activation state of each 
protein. This is because the ability of each protein 
to interact with its substrates or partners is 
regulated by post-translational, chemical 
modifications that alter or stabilise specific 
conformations or shapes in each protein to drive or 
prevent interactions with specific partners. To take 
such a detection ability to a high-throughput 
quantitative format is highly desirable, particularly if 
the low detection limits required clinically can, 
additionally, be realised. 
Several studies on the use of technologies 
underway. Although these approaches had some 
developed for DNA microarrays for the 
characterization of proteomes are presently 
5,6 
success in protein expression profiling, the scope of 
applications has been limited. One of the main 
aspects hampering the development of these array-
based approaches is the need to use labels such 
as enzymes or fluorescent tags. Unlike the case of 
DNA, labelling a protein with a molecular tag can 
strongly affect its binding properties and the yield of 
7
the target-label coupling reaction is highly variable.
Label-free electrical detection techniques suitable 
for protein interactions are therefore of considerable 
interest. Several electrochemical techniques have 
8-10 
been proposed for the detection of proteins.
Impedance-based sensors and field-effect devices, 
in particular, are promising candidates for the 
development of inexpensive microarrays associated 
with portable instrumentation. Field-effect 
transistors with metal gate electrodes, such as 
11 
those previously developed for DNA sensing, are 
an example of such sensors. These stable 
semiconductor devices measure variations in the 
open circuit potential (OCP) that occur at the metal 
gate interface when the charge density and 
distribution of the immobilized bio-layer change 
upon interaction with a target biomolecule. 
A major limitation in the production of devices for 
the detection of biomolecules, however, is the 
availability of robust probes that are able to 
specifically detect the target biomolecule. 
Traditionally, antibodies have been the affinity 
probes of choice in biology. Antibodies are proteins 
that comprise a constant region that interacts with 
effectors of the immune system and the variable 
recognition moiety, which specifically recognizes 
and binds to target molecules. However, many 
antibodies are found to lose their specificity when 
12 
immobilized on surfaces. A range of alternative 
affinity probes exist, including engineered proteins 
13 
that do not use the antibody scaffold. In common 
with these, peptide aptamers are artificial proteins 
2 
engineered to possess the affinity and specificity of 
antibodies, but they differ from the other engineered 
proteins in being designed to retain their integrity 
14 
within the context of a eukaryotic cell. The peptide 
aptamer scaffold is thus chosen for its biological 
simplicity and structural stability. As with the 
variable region of antibodies, peptides inserted into 
the primary sequence of the scaffold (by 
manipulation of the gene encoding it) are forced to 
adopt a particular fold dictated by the folding of the 
scaffold, and become able to bind to specific 
partners with high specificity and affinity.
13,14 
We 
have introduced a new non-antibody scaffold, called 
Stefin A Triple Mutant (STM) that lacks significant 
15 
affinity for human proteins and have been able to 
show that peptide aptamers presented by STM can 
be immobilized using a range of surface 
chemistries while still retaining the ability to detect 
16-21 
their partners. Of key relevance here, protein 
detection has recently been achieved by direct 
differential measurement of OCP variations using 
an ultra-low input bias current instrumentation 
17 
amplifier. The biological system assessed here 
consisted of a panel of peptide aptamers that 
recognise specific protein partners of the cyclin-
dependent kinase (CDK) family, whose activity is 
important in proliferating and cancerous cells. 
We report here the use of extended gate metal-
oxide-semiconductor field-effect transistors 
(MOSFETs) for label-free electrical detection of 
proteins. Low-leakage single-crystalline MOSFETs 
fabricated using Complementary Metal–Oxide– 
Semiconductor (CMOS) technology were 
connected to external gold electrodes on which 
orientated peptide aptamers were covalently 
immobilized. The interaction between the peptide 
aptamers and the protein CDK2 (a protein known to 
be active in proliferating cells, including cancer 
cells) was probed as a test study for a generic 
sensitive method for detection of protein 
interactions. Concentration profiles were obtained 
showing an ultra-low protein detection limit. 
EXPERIMENTAL SECTION 
Protein preparation. Details of peptide 
aptamers, protein expression and purification, have 
been reported elsewhere.
15,16,18 
The expression 
vector used drives the incorporation of a single 
cysteine residue in the amino-terminal tail encoded 
by the pHTLV1 vector in order to allow a 
controllable immobilization on gold substrates. 
STM
Cys+ 
and STM
Cys+
–pep2 were expressed as 
hexahistidine fusion proteins in Escherichia coli 
cells. The full amino acid sequences of STM, 
STM
Cys+ 
and STM
Cys+
–pep2 are presented in Table 
1. Including the Cys+ extension, STM is 159 amino 
acids long and has a predicted molecular weight of 
18 kDa while STM-pep2 is 181 amino acids long 
with a predicted molecular weight of 20 kDa. 
Recombinant CDK2 was purchased from Abnova 
(Taiwan). A CDK-free yeast lysate was used as a 
17-18 
control. Briefly, the CDK2 gene was cloned into 
the yeast expression vector pDEST32 (Invitrogen) 
and transformed into MAV203 yeast cells as 
17-18 
described previously. . A 5 ml culture of yeast 
was grown in selective dropout medium lacking 
leucine to OD600=4 (corresponding to 
8
0.8x10 cells/mL). The culture was then centrifuged 
for 10 min at 3200 × g, the supernatant removed 
and the cell pellet resuspended in 400 µl of Y-Per™ 
yeast protein extraction reagent (Pierce) with 
protease inhibitor (Roche). The protein extraction 
reaction was performed at room temperature with 
regular vortexing for 30 min. The sample was then 
submitted to centrifugation at 16,000 × g for 10 min 
and the soluble fraction stored at -80°C until use. 
Human cell lysate was prepared from actively 
proliferating human DG75 cells that express CDK2. 
DG75 cells were grown in RPMI medium (GIBCO) 
supplemented with 10% fetal bovine serum, 
50 U/mL penicillin and 50 µg/mL streptomycin. The 
cells were collected, washed with pre-chilled PBS 
(pH 7.2) and lysed by sonication in lysis buffer 
(20 mM HEPES, pH 7.5, 150 mM KCl, 0.1 mM 
EDTA, 10% glycerol, 0.1% NP-40, 1 mM DTT, 
protease inhibitor cocktail (Roche), 1 mM PMSF) at 
4°C. The resulting cell lysate was centrifuged with 
an Eppendorf 5310R at 13,000 rpm for 20 minutes 
at 4°C. The supernatant was transferred to pre-
chilled clean vials, flash-frozen and stored at -80°C 
until use. 
3 
Table 1. Amino acid sequence and size of STM, STM
Cys+ 
and STM
Cys+
-pep2. 
protein 
STM 
STMCys+ 
STM
Cys+
-pep2 
sequence 
number of 
amino 
acids 
estimated 
molecular 
weight (Da) 
mipwglseakpatpeiqeivdkvkpqleektnetygkleavqyktqvdagtnyyikvragdnkymhlkvfngppgqnedlvltgyq 
vdknkddeltgf 
98 11074 
MHHHHHHSSGLVPCGSGMKETAAAKFERQHMDSPDLGTWSHPQFEKYDDDDKAMADIGSE 
Fmipwglseakpatpeiqeivdkvkpqleektnetygkleavqyktqvdagtnyyikvragdnkymhlkvfngppgqnedlvltgy 
qvdknkddeltgf 
159 17950 
MHHHHHHSSGLVPCGSGMKETAAAKFERQHMDSPDLGTWSHPQFEKYDDDDKAMADIGSE 
FmipwglseakpatpeiqeivdkvkpqleektnetygkleavqyktqvdagtnyyikvragdnkymhlkvfngpLVCKSYRL 
DWEAG ALFRSLFgppgqnedlvltgyqvdknkddeltgf 
181 20461 
Notes: The Cys+ tail is presented in capital letters and the pep2 insert in bold capital letters. The cysteine in position 
14 (underlined) is used for the immobilization of the proteins. 
Materials. All chemicals were purchased from 
Sigma-Aldrich (UK) with the exception of the 
thiolated polyethylene glycol (Asemblon, USA). All 
proteins and lysates were diluted to the desired 
concentration in 10 mM phosphate buffer (PB) 
pH 7.2. Buffers were prepared by mixing the 
appropriate amounts of KH2PO4 and K2HPO4 using 
ultra pure deionized water (18.2 MΩ.cm resistivity). 
The total ionic strength of the phosphate buffer 
amounts to 21 mM. The concentrations presented 
for the lysates refer to the total concentration of all 
cellular proteins in the lysate. 
Field­effect transistor set­up. Single-crystalline 
Si MOSFETs were fabricated using a CMOS 
0.7 µm process at IMEC (Belgium). The devices 
have no electrostatic discharge (ESD) protection 
elements in order to minimize their gate leakage 
current. Each chip contains five n-type MOSFETs 
with a common source contact. Different sized 
transistors have been used with widths (W) and 
lengths (L) ranging from 1340 µm to 3860 µm and 
2.0 µm to 0.7 µm, respectively, while keeping the 
2
W×L product at approximately 2700 µm . The chip 
was glued on a glass substrate containing 
evaporated gold electrodes (100 nm Au with 10 nm 
Cr as adhesion layer) consisting of a bonding pad 
connected to a 500 µm x 500 µm pad. The on-chip 
gate contact pads were wire-bonded to the Au 
electrodes as shown in figure 1 and the source, 
drain and substrate contact pads were wire-bonded 
to a printed circuit board (PCB). The chip was first 
passivated with Glob-Top (Amicon) epoxy 
encapsulant and then both the chip and the Au 
bonding wires were passivated with a low viscosity 
silicone rubber (3140 RTV coating from Dow 
Corning). The Au electrodes on the glass substrate 
were patterned with 50 µm SU-8 to open 
380 µm x 380 µm windows on top of the Au pad. 
When the glass chip is immersed in an electrolyte, 
only these exposed Au areas are in contact with the 
solution. The characteristics of the transistors were 
measured using a semiconductor parameter 
analyzer (HP4156A, Hewlett Packard, USA). It 
should be noted that instabilities were observed on 
a few chips resulting in abnormally high shifts in 
transfer characteristics upon interaction with a 
target (specific or otherwise). On these chips a 
strong time dependence of the signals was 
observed and all the transistors in the same chip 
showed very different signals – these criteria were 
used to identify unstable chips. 
Immobilization and interaction procedures. 
Prior to protein immobilization, the Au electrodes 
were rinsed with acetone and then isopropanol. The 
electrodes were then cleaned in a UV/Ozone 
system (Novascan PSD-UVT, USA) followed by 
ethanol and ultra-pure water rinses. Cysteine 
modified STM or STM-pep2 was immobilized from 
a 1 µM solution in 10 mM phosphate buffer (PB) 
4 
Figure 1. Schematic structure of a linear array of five 
MOSFETs with extended gold gates. The gate contact 
pads are wire-bonded to gold electrodes evaporated on 
glass. Only the gold pad electrodes are exposed to the 
electrolyte. S, D1-5 and G1-5 are the on-chip contact pads for 
source, drains and gates, respectively. 
pH 7.2 onto the freshly cleaned gold electrodes for 
1.5 hours in a humidity chamber. Prior work has 
demonstrated the retention of robust and specific 
biorecognition on both bare and modified gold 
16-18 
electrode surfaces. The thickness of an 
STM
Cys+ 
layer has previously been measured to be 
18 
2.7 nm by dual polarization interferometry. After 
rinsing in the same buffer to remove unbound 
peptide aptamers, the exposed gold areas were 
passivated with a thiolated alkane polyethylene 
glycol (PEG) by exposing the electrodes to a 50 µM 
solution of HS(CH2)11(OCH2CH2)3OH in 10 mM PB 
for 1.5 h in a humidity chamber. The samples were 
subsequently rinsed in buffer to remove any non-
immobilized molecules. 
Throughout the measurements the substrate was 
kept grounded through the source while in between 
measurements the electrolyte was kept connected 
to the source. The transistor's transfer 
characteristics were measured with the drain to 
source voltage, VDS, held at 1 V. The gate to source 
voltage, VGS, was applied through a Hg/Hg2SO4 
reference electrode immersed in the measurement 
electrolyte via a salt bridge. VGS was varied 
between -0.5 V and +2 V and the drain current was 
measured. Only the transistors that showed no 
hysteresis were used in the present study. 
The functionalized electrodes were exposed to 
lysates containing the target protein CDK2 as well 
as high concentrations of non-specific proteins for 
30 minutes in a humidity chamber, followed by 
rinsing in buffer. The transfer characteristics of the 
transistors were measured before and after 
incubation. Parallel shifts of the transfer 
characteristics are observed upon interaction. The 
voltage shifts here presented were taken at 
ID = 1 µA. 
Transistor response concentration profiles were 
measured by injecting 10-20 µl of pre-concentrated 
stock solutions of recombinant CDK2 into a 
measurement cell containing 1.5 ml of 10 mM PB 
pH 7.2. Upon injection, the solution was stirred for 
15 min with a magnetic stirrer to allow uniform 
mixing of the protein with the buffer and then 
allowed to thermally equilibrate for 15 min at room 
temperature. The measurements were carried out 
with the magnetic stirrer switched off to reduce 
noise. 
RESULTS AND DISCUSSION 
When a bio-layer is immobilized on an electrode 
bathed in a solution of electrolyte, the change in the 
charge density and/or distribution at the interface 
between the electrode and the electrolyte brought 
about by a biomolecular interaction induces a 
change in the open circuit potential (OCP) of the 
system. Although reliable measurements of OCP 
variations in protein systems have been achieved 
recently using an ultra-low input bias current 
17 
instrumentation amplifier, better sensitivities in 
OCP measurements can be achieved with field-
effect transistors (FETs) since parasitic 
capacitances are minimized. FETs have inherent 
amplification, high-input impedance, low-output 
impedance, and potential for miniaturization and 
multiplexing. When the bio-layer is immobilized at 
the FET’s metal gate, variations in the OCP brought 
about by a biomolecular interaction are accurately 
measured by a shift in the transfer characteristics 
(drain current ID versus gate voltage VGS) of the 
5 
FET, as previously demonstrated for the detection 
11 
of DNA hybridization.
In order to take advantage of previously 
developed STM
Cys+ 
immobilization protocols,
16 
gold 
electrodes were externally connected to the 
aluminium gate contact pads of the MOSFETs. 
Special care has to be taken during the electrode 
connection to avoid device failure due to 
electrostatic discharge (ESD) effects. As the gate 
voltage is applied on these external gold electrodes, 
any change in the OCP modulates the transistor’s 
gate voltage. This approach creates in effect an 
extended-gate structure. This configuration has the 
advantage that the FET itself is not exposed to the 
electrolyte. This prevents the typical effects of 
signal drift caused by permeability of the gate 
22 
dielectric to alkaline cations.
As the gate voltage with respect to the source is 
applied on the reference electrode immersed in the 
bulk of the electrolyte, the transfer characteristics 
are expected to shift positively upon an increase of 
negative charge or a decrease of positive charge at 
the bio-layer interface. Negative shifts are expected 
upon the reverse charge variations. The device is 
then sensitive to variations in charge distribution at 
the gold electrode. Previous work has 
demonstrated that variations in the charge 
distribution at the bio-layer induces changes in the 
OCP, which can be measured by the use of suitable 
17 
instrumentation. In order to confirm that the same 
variations in OCP can also be measured with our 
FET set-up, the scaffold protein without a peptide 
insert, STM
Cys+ 
, was immobilized on the gold 
electrodes and the transfer characteristics of the 
transistor measured at different pH values of a 
10 mM phosphate buffer. We find that the MOSFET 
response is pH-independent when no biomolecule 
is immobilized on the gold electrode (data not 
shown). However, changes in the surface charge of 
immobilized STM
Cys+ 
occur upon variations in the 
pH of the electrolyte, due to 
protonation/deprotonation of solvent-exposed 
amino acid side-chains. Since the aptamer layer 
18 
thickness is comparable to the Debye length of 
the measurement buffer (~2.5 nm) these protein 
Figure 2. Transfer characteristics of a STMCys+

functionalized n-channel transistor with size

W/L=3860 µm/0.7 µmupon variations of pH of the

measurement electrolyte. The pH of the 10 mM PB buffers

was varied between pH 6.6 and pH 7.6. VDS was kept at 1 V.

The error bars are smaller than the data points and were

removed from the figure.

electrode. In the example shown in figure 2, the 
transfer characteristics shift by +32.7 mV on 
changing pH from 6.6 to 7.1 and by +23.2 mV on 
changing pH from 7.1 to 7.6. The measurements 
were carried out in the pH sequence of 7.1 → 7.6 
→ 6.6. On returning the buffer to pH 7.1, the curve 
returned to its original position within 0.3 mV. 
Similar voltage shifts were confirmed with different 
devices. Variations in the total ionic strength of the 
PB solutions associated with the pH changes have 
been shown to account for only a small amount of 
17 
the total OCP variation. These results 
demonstrate that our devices are sensitive to 
variations in protein charge brought about by 
varying the pH of the surrounding electrolyte. 
The use of CMOS MOSFETs with externally 
connected gold electrodes for the detection of 
protein interactions was studied for the peptide 
aptamer STM
Cys+
–pep2, which has a strong 
interaction with the protein CDK2.
15,19 
Figure 3 
shows the transfer characteristics of two MOSFETs 
after immobilization of the peptide aptamer. Upon 
interaction with a human cell lysate expressing 
CDK2, a shift of +26.7 ± 3.8 mV is observed (figure 
3a). The direction of the shift is consistent with the 
results obtained with direct OCP measurements for 
charge variations are directly detectable at the 
6 
Figure 3. Transfer characteristics of two n-channel transistors with sizes W/L = 1630 µm/1.6 µm after immobilization of 
STMCys+–pep2 and after interaction with: (a) 10 µg/ml of human cell CDK2 lysate and (b) 10 µg/ml of CDK-free yeast 
lysate. VDS was kept at 1 V. The error bars are smaller than the data points and were removed from the figure. 
17 
the specific interaction. As a control, transistors 
functionalized with the peptide aptamer were 
exposed to a CDK-free yeast lysate, resulting in a 
small shift of +4.1 ± 4.4 mV (figure 3b) due to non-
specific interaction with some of the proteins 
present in the lysate. Both lysates had a total 
protein concentration of 10 µg/ml. 
The gold-thiol chemistry employed for the 
immobilization of STM
Cys+
-pep2, ensures that the 
peptide aptamer orientation on the surface is 
controlled and regular with the peptidic inserts 
readily available for interaction with the target 
proteins. Bound target is therefore expected to form 
a defined layer within the electrochemical double-
layer. This attribute of interfacial probe orientation is 
necessary to meaningfully consider the effect of the 
charge of the analyte onto the sensing gold pad. 
As the concentration of CDK2 in the lysates is 
unknown, binding curves were acquired with 
solutions containing known concentrations of 
purified recombinant CDK2. The transfer 
characteristics of several transistors with STM
Cys+
– 
pep2 immobilized on the extended gold electrodes 
were measured upon injection of CDK2 into the 
measurement buffer. Figure 4 shows the average 
gate voltage shifts observed on two transistors for 
CDK2 concentrations ranging from 21 fM 
(1.2 pg/ml) to 1.9 nM (110 ng/ml). Measurable 
signals were obtained even for the lowest 
concentrations. For protein concentrations of 
~100 fM, shifts of the order of 1 mV (± 0.1 mV) are 
reproducibly measured. 
The binding curve (Figure 4) is not expected to 
follow a traditional Scatchard-Rosenthal affinity 
23 
model, where the signal depends on the analyte 
concentration c and the dissociation constant Kd as 
c/(Kd+c). This model assumes that the signal is 
directly proportional to the amount of bound target. 
In the present case, the measured potential 
variation has a non-linear dependence on the 
charge density: using the Gouy-Chapman-Stern 
model for the electrochemical double layer, the 
potential varies as the inverse hyperbolic sine of the 
11 
charge density. Furthermore, since the bound 
CDK will sit further away from the electrode than 
the Debye length, its charge will be partially 
screened by the electrolyte, which implies that the 
charge density of the bio-layer does not necessarily 
have a linear dependence on the amount of bound 
CDK. The binding curve seems to have a logistic-
model has not been possible presumably due to 
type behaviour characteristic of immunoassays, 
although a fit using a four-parameter logistic 
24 
the low concentration range studied. 
Even though the bound CDK2 is expected to 
extend over a large distance from the surface, large 
7 
Figure 4. Gate voltage shifts observed at ID = 1 µA for 
transistors functionalized with STM
Cys+
–pep2 upon in-situ 
interaction with CDK2. The CDK2 concentrations were 
varied between 21 fM (1.2 pg/ml) and 1.9 nM (110 ng/ml). 
The data represent the average of the shifts obtained for 2 
adjacent transistors with sizes W/L = 3860 µm/0.7 µm and 
W/L =2670 µm/1.0 µm. The line is a guide to the eye. 
signals are observed using the present MOSFET 
configuration. The nature of the signal is likely to be 
a combination of different effects. We have 
previously reported a negative shift of the OCP 
upon interaction and the concomitant increase of 
the charge transfer resistance, extracted from 
electrochemical impedance spectroscopy 
measurements with negative redox couple in 
17 
solution. This supports the explanation that the 
interaction produces a more negative potential 
barrier at the SAM/electrolyte interface, which is 
consistent with the observed shift of the transistor 
characteristics. That said, the situation here is quite 
different from the classical picture of a planar 
interface and uniform electrochemical double layer. 
Assessing the role of target position relative to the 
double layer, would require implementation of more 
sophisticated models, taking into account the 
discreteness of the charges and the fundamentally 
25 
three-dimensional nature of the double layer.
Conformational changes of the biolayer upon 
26 
interaction may also occur.
The specificity of the interaction of different 
immobilized STM-based peptide aptamers to CDK 
proteins has been previously demonstrated by 
SPR,
16,21 
QCM,
17 
microcantilever,
20 
electrochemical 
impedance spectroscopy,
17,19 
dual polarization 
18 17 
interferometry, and direct OCP measurements. 
The interaction can be turned off by changing or 
removing the peptide insert. For the MOSFETs 
here reported, control experiments carried out with 
immobilized scaffold adlayers without the 
recognition sequence (STM
Cys+
) were associated 
with <5 mV shifts at high nanomolar CDK2 
concentration. Analogous control experiments with 
the STM
Cys+
–pep2 aptamer surface responded with 
shifts lower than 4 mV to high (micromolar) levels 
of BSA, indicating that further work is required to 
prevent non-specific interactions when large 
amounts of interfering compounds are present in 
the sample. Nevertheless, the present results 
suggest that stable MOSFETs with extended metal 
gates can be used for label-free electrical detection 
of proteins with an ultra-low detection limit. 
CONCLUSIONS 
Sub-picomolar label-free electrical detection of 
proteins has been achieved using MOSFETs in a 
novel approach. Gold electrodes externally 
connected to the gate contact pad of the MOSFETs 
act as extended gates for the transistors where 
biomolecular interactions take place. Using a 
peptide aptamer and a cell marker protein as a test 
system, protein concentrations of the order of 
100 fM (or 5 pg/ml) have been detected. This the 
first time that such low protein concentrations have 
been detected using CMOS-based label-free 
electrical devices. The presented electrode 
configuration with the transistor buried under a 
passivation layer enables the use of low-cost 
CMOS processes for the fabrication of biologically-
sensitive MOSFETs. 
In the 1.5 ml measurement cell used, the low 
7
concentration detected corresponds to 9×10
protein molecules in the solution. Through 
appropriate design, the size of the gate electrode 
and the volume of the measurement cell can be 
reduced by two orders of magnitude or more, 
enabling, in theory, at these levels of sensitivity, 
detection of just a few thousand molecules. 
MOSFET-based sensors are intrinsically suited to 
miniaturization since the signal is independent of 
8 
the device size. Another advantage is that only a 
reference electrode is required, instead of the 3-
electrode potentiostatic arrangement needed for 
current-based detection. A multiplexed array of 
MOSFET devices is presently being fabricated. The 
array will have the gold electrodes monolithically 
integrated on the chip. 
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